Novel Diagnostic and Therapeutic Approach to Antibody-Mediated Rejections in Heart Transplantation
Despite the improvement of immunosuppressive therapy in heart transplantation (HTx), antibody-mediated rejection (AMR) is still a great obstacle to prolong cardiac graft survival. Anti-donor-specific antibodies (DSAs), especially anti-donor human leukocyte antigen (HLA) antibody, lead to heart graft...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2020
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/72606 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Novel Diagnostic and Therapeutic Approach to Antibody-Mediated Rejections in Heart Transplantation
- Donor Assessment and Management for Heart Transplantation
- Current and Future Directions in Antibody-Mediated Rejection Post Kidney Transplantation
- Detection of Antibody-Mediated Rejection in Kidney Transplantation and the Management of Highly Sensitised Kidney Transplant Recipients
- Heart Transplantation and Mechanical Circulatory Support in Japan – Past, Current and Future Aspects
- Sarcopenia in Patients with End-Stage Cardiac Failure Requiring Ventricular Assist Device or Heart Transplantation
- Advances in Antibody Mediated Rejection